DATA SHEET PRODUCT NAME - Medsafe
Page 1 of 15 DATA SHEET 1. PRODUCT NAME JANUVIA® 25 mg film-coated tablets JANUVIA® 50 mg film-coated tablets JANUVIA® 100 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Download DATA SHEET PRODUCT NAME - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
RESEARCH AND DEVELOPMENT M. PHARM …
maliba.edu.inRESEARCH AND DEVELOPMENT M. PHARM THESIS 2011-12 Pharmacology Sr. No. Project title Name of Student Name of Guide 1 Effectiveness of Boerhaaviadiffusa and Punicagranatum in experimental prostatic
Sitagliptin Phosphate: Development of a …
www.dissolutiontech.comDissolution Technologeis | MAY 2014 17 Sitagliptin Phosphate: Development of a Dissolution Method for Coated Tablets Based on In …
ASSESSMENT REPORT FOR Janumet
www.ema.europa.eu6/43 an adjunct to diet and exercise in patients inadequately controlled with any two of the three agents: metformin, sitagliptin, or a sulphonylurea.
Noninsulin Diabetes Medications Summary Chart …
www.joslin.org2 med group descriptor drug class drug name action side effects notes dosage (mg/tab) dosing frequency/day dosing range (mg/day) metformin sustained
API Product List - Jubilant Life Sciences
www.jubl.comAPI Product List DMFs Filed Alendronate Sodium Aripiprazole Atorvastatin Amorphous Azithromycin Dihydrate Azithromycin Monohydrate Bupropion Hydrochloride
捷糖穩 50/500 50/850 JANUMET 50/500 mg Film …
www.ktgh.com.tw2 治療分類 JANUMET JANUMET (sitagliptin phosphate/metformin HCl)係由兩種作用機轉互補的抗高血糖藥物組合 而成，用於改善第二型糖尿病患者的血糖控制：其中 ...
NIHS 医薬品安全性情報 Vol.13 No.20 201510/08/
www.nihs.go.jp医薬品安全性情報Vol.13 No.20（2015/10/08） 3 • DPP-4阻害薬には，sitagliptin，saxagliptin，linagliptin，alogliptinなどがある。
EUROPEAN PHARMACOPOEIA 9.1 …
www.edqm.euEUROPEAN PHARMACOPOEIA 9.1 Contents of Supplement 9.1 CONTENTSOFSUPPLEMENT9.1 A vertical line in the margin indicates where part of a text has been revised or corrected. A horizontal line in the ...
Related search queries
RESEARCH AND DEVELOPMENT M. PHARM, RESEARCH AND DEVELOPMENT M. PHARM THESIS 2011, Sitagliptin Phosphate: Development of a, Sitagliptin Phosphate: Development of a Dissolution, ASSESSMENT REPORT, Sitagliptin, Noninsulin Diabetes Medications Summary Chart, API Product List, Sitagliptin phosphate, EUROPEAN PHARMACOPOEIA 9.1